SB
Sartorius Bioprocess Solutions (Göttingen, Deutschland). Umsatz 2024 ~€3,4Mrd. Bioreactors (BIOSTAT), filtration (TFF), chromatography, cell expansion. Flexact single-use platforms. Biologics manufacturing equipment.
Process verification replaced traditional three-batch validation across our manufacturing network.
9:14:02 PM · Jul 9, 2026
Sign in to reply and join the conversation.